THIS SHARE WILL BE WORTH 3.00 IN 2009

Quite agree.

This week could be interesting I feel PTI is about to wake a few people up!!!

There must be some news in the pipeline.

I think it's anyones guess at the moment re the markets.
What with the cost of oil, sub-prime still bubbling, the dollar situation, Pakistan, Iraq, Turkey/Iran the UK debt, global warming, floods, road congestion, household bills, my bank statement, wifes Xmas wants (ba humbug), ad infinitum.
Think I will hibernate till it's all over.

Depends on what you mean by "all over". Suggest you buy a sandwich board and patrol outside the Stock Exchange!

Hi Halifax,

Just think what my views would be if I was a pessimist and not an optimist.
But seriously, I think Protherics are in a very good position re their drug portfolio, to greatly increase the sp either on a world stock market pick-up or/and on a positive significant news release re one of their drugs in trial.
In Potherics, I think we are as safe (and safer than many companies) as anywhere at the present.

With the build up of Axa and the results out tomorrow, looking forward to 0700 hrs.
With blood all over the markets, PTI had a very good day.

The only conclusion I can come to re the SP is the loss that Protherics is making.
Loss is the only negative in the results, although if you look at the loss along with the other figures, it is only the result of the increase in R&D.
Revenue growth is up 31%.
Gross profit up 32%.
Margins about the same at 55.4% (all down to an excellent management team).
Loss before tax up 6.1 mil. (because of the R&D increase).
Net cash up 14.4 mil.
CASH....46.9 mil (so if the same loss bt continued, it could be carried for several years).

Most will look at these figures as indicating a company well on track for profit within the next 12 months with a very prosperous few years ahead.

Because Protherics are a small, market value drug/bio company compared to those bigger boys in the sector who are year by year well into profit making in huge numbers, the share seams to stall whenever the word LOSS is mentioned, or/and the word delay.

Protherics must have the best (for it's size) drug portfolio in the sector, but as we have seen many times, as soon as there is a delay for whatever reason of a drugs progress, the sellers pile in.

I expect delays, disappointments along the way. Thats the way of the beast.
If half of the drug pipeline make it to full production, I will be happy.
And half is well above all drugs from initial conception to full use acceptance.

My belief is that many holders in the past, with probably some still holding just don't understand the ways of such companies products.

I for one will continue to hold for what I believe the future has in store for Protherics.

If only more PI's would look at the fundamentals and compare Protherics with their competitors, of a similar size, and forget at this stage the EPS.

OK if you want Protherics to make you money now then forget it (allowing for the possible upgrade in market sentiment of course). But if you want to be in on the big party, don't wait till the entry fee costs go up.

All IMHO of course.

Nice little BUY recommendation from The Independent. Nothing that we don't know from yesterday but the more interest the better.

Protherics, one of the UK's most established biopharmaceutical companies, is gearing up for a big 2008. It is second-nature for life sciences companies to point to jam tomorrow, but with six products entering phase II trials over the next six months, Protherics is able to boast that it has a larger development pipeline than any other UK biotech.

Yesterday's interim results illustrate why Protherics is well-regarded. The company's underlying revenue growth was an impressive 41 per cent at constant currency rates, while its pre-tax loss of 6m was much better than had been expected.

Perhaps more significantly, Protherics reported a cash pile of 47m, giving it the firepower to continue to develop a number of potential blockbuster drugs under its wing.

Be nice to see if there is further institutional interest over next 6 to 12 months.

Biotech recruiter Accord Scientific has partnered with international biopharmaceutical company Protherics Inc. to build Protherics' clinical regulatory and senior staff.

Accord was selected to support Protherics after Protherics' acquisition of Utah-based MacroMed Inc., a private drug development and manufacturing company and two in-licensing agreements the company has signed with Glenveigh Pharmaceuticals and Advancell of Barcelona. The three transactions have roughly doubled the size of Protherics' U.S. Operations.

Proves PTI's are treating the USA projects very seriously.

How much of the recent weakness is due to Market-fear and folks wanting their Cash back? ( i.e. At any reasonable price).

So do we expect further weakness to sub 50-pence?

40p anyone?

Frankly, I can't see 3.00 anytime, not 2009.= soon . . . . . Not until we see some returns and can price the risk/reward, don't you know?

Sp up 4.13% on average volume. Will be interesting to see if there are any institutional buys that come in on Wednesday.

I foresee a good year for Protherics due to their cash position (even more important in the present credit situation) and their drug portfolio.

Happy New Year all.

PTI has a market cap close to 200m as an ex shareholder I would like to believe that 2008 will prove to be the year they achieve something tangible but I have my doubts thats why Iam out.

Sp up 16.27% @ 8.5p. Last time there was a distinct move up I was looking for a reason, can't really find one unless there is a big buyer out there due to the latest RNS. The problem is with the markets as they have been last 4 months, it's up and down like the proverbial yo yo. But with todays increase surely somethings in the wind.

Probably this rise was this a knock on effect of:

Meldex International confirms potential offer approach received
AFX


LONDON (Thomson Financial) - Meldex International PLC said it has received an approach which may or may not lead to an offer for the company.

A further announcement will be made in due course, the specialty pharma and healthcare company added.

Hi Tau Ceti,

Could be but seems a good hike on price just because of the Meldex news.

Cheers Greek.

It's a big rise for the last half hour of trading. Can't think it could be just a 'Meldex effect' as some other pharmacos might have been similarly affected. I wonder if there could be some announcement first thing tomorrow? Will certainly keep a close eye on this but, as Greekman says: beware of the yoyo effect with this one!

Im long long suffering shareholder - is this the time for payback?! - I H O P E SO!!!!!!1

Hi Greek,
The Meldex news came out at 3:30 and Protherics started its rise shortly afterwards so that's why I thought they were connected.
TC.

I agree the timing is strange re the uptick. Funny thing is the pharma/bio sector was one of the biggest loosing sectors yesterday. Curiouser and curiouser.

Some day traders must be making/loosing a mint on this. All down to timing. Can't read this share or the market at all of late.